Publikationen von Udo Reichl
Alle Typen
Zeitschriftenartikel (267)
61.
Zeitschriftenartikel
117 (5), S. 1533 - 1553 (2020)
A dynamic model linking cell growth to intracellular metabolism and extracellular by‐product accumulation. Biotechnology and Bioengineering 62.
Zeitschriftenartikel
14 (3), e0212757 (2019)
A system for production of defective interfering particles in the absence of infectious influenza A virus. PLoS One 63.
Zeitschriftenartikel
37 (47), S. 7003 - 7010 (2019)
Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production. Vaccine 64.
Zeitschriftenartikel
37 (47), S. 7011 - 7018 (2019)
Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems. Vaccine 65.
Zeitschriftenartikel
24 (19), 3482 (2019)
Enzymatic Cascades for Tailored 13C6 and 15N Enriched Human Milk Oligosaccharides. Molecules 66.
Zeitschriftenartikel
14 (3), 1800305 (2019)
Enzymatic cascade synthesis provides novel linear human milk oligosaccharides as reference standards for xCGE-LIF based high-throughput analysis. Biotechnology Journal 67.
Zeitschriftenartikel
Use of sulfated cellulose membrane adsorbers for chromatographic purification of cell cultured-derived influenza A and B viruses. Separation and Purification Technology (226), S. 350 - 358 (2019)
68.
Zeitschriftenartikel
37 (47), S. 7019 - 7028 (2019)
Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1. Vaccine 69.
Zeitschriftenartikel
10, 1883 (2019)
A Robust and Universal Metaproteomics Workflow for Research Studies and Routine Diagnostics Within 24 h Using Phenol Extraction, FASP Digest, and the MetaProteomeAnalyzer. Frontiers in Microbiology 70.
Zeitschriftenartikel
Metaproteome analysis reveals that syntrophy, competition, and phage-host interaction shape microbial communities in biogas plants. Microbiome (7), 69 (2019)
71.
Zeitschriftenartikel
15 (2), e1006759 (2019)
RedCom: A strategy for reduced metabolic modeling of complex microbial communities and its application for analyzing experimental datasets from anaerobic digestion. PLoS Computational Biology 72.
Zeitschriftenartikel
93 (4), 01786-18 (2019)
A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome. Journal of Virology 73.
Zeitschriftenartikel
15 (4), e1006944 (2019)
Model-based analysis of influenza A virus replication in genetically engineered cell lines elucidates the impact of host cell factors on key kinetic parameters of virus growth. PLoS Computational Biology 74.
Zeitschriftenartikel
201, S. 93 - 103 (2019)
Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis. Journal of Proteomics 75.
Zeitschriftenartikel
18 (1), S. 3 - 15 (2019)
High-throughput serum N-glycomics: method comparison and application to study rheumatoid arthritis and pregnancy-associated changes. Molecular and Cellular Proteomics 76.
Zeitschriftenartikel
15 (2), e1006819 (2019)
Multiscale modeling of influenza A virus replication in cell cultures predicts infection dynamics for highly different infection conditions. PLoS Computational Biology 77.
Zeitschriftenartikel
7, 275 (2019)
Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times—Insights From qPCR Measurements and Viral Dynamics Modeling. Frontiers in Bioengineering and Biotechnology 78.
Zeitschriftenartikel
14 (11), e0224317 (2019)
Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the “von Magnus effect”. PLoS One 79.
Zeitschriftenartikel
103 (7), S. 3025 - 3035 (2019)
High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system. Applied Microbiology and Biotechnology 80.
Zeitschriftenartikel
1117, S. 103 - 117 (2019)
Hydrophobic-interaction chromatography for purification of influenza A and B virus. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences